Source: Annual Congress 2001 - Interstitial lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Boros, L. Radwan, J. Kowalski (Warsaw, Poland). Total lung capacity (TLC) or vital capacity (VC) - which is more reduced in interstitial lung disease (ILD) patients?. Eur Respir J 2001; 16: Suppl. 31, 1028

Member's Comments

No comment yet.

Related content which might interest you: Static lung compliance (Cst) and diffusion lung capacity (DLCO) as markers of lung function impairment in sarcoid patients with normal lung volumes Source: Eur Respir J 2003; 22: Suppl. 45, 278s Year: 2003 Analysis of patients with idiopathic pulmonary fibrosis (IPF) with percent predicted forced vital capacity (FVC)<50% treated with pirfenidone (PFD) in RECAP Source: International Congress 2016 – IPF treatment I Year: 2016 How reliable is total lung capacity (TLC) measured during single breath (SB) diffusion capacity test (DLCO) comparing to plethysmography (PL) method in diabetic subjects with normal lung function? Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 Nasal high-Flow (NHF) improves ventilation in patients with interstitial lung disease (ILD) Source: International Congress 2019 – Hot topics in noninvasive ventilation Year: 2019 Exercise limitation in patients with interstitial lung disease independent from diffusion capacity (DLCO) Source: Annual Congress 2008 - Exercise: system responses Year: 2008 Safety of sputum induction (SI) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Influence of smoking habit on static lung compliance (Cst) in interstitial lung diseases (ILD) patients Source: Eur Respir J 2002; 20: Suppl. 38, 194s Year: 2002 Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD) Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD) Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure Year: 2009 Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Determination of total lung capacity (TLC) without body plethysmography Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function Year: 2013 Lung Clearance Index (LCI) and diffusion capacity of the lung (DLCO) in children with rheumatic disease Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009 The Gender-Age-Physiology (GAP) Index enhanced with KL-6 serum level for predicting disease progression in interstitial lung diseases (ILD). Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Six minute walk distance (6MWD) and pulmonary diffusing capacity (DLCO) in patients with COPD Source: International Congress 2015 – COPD: notable points Year: 2015 Percent predicted forced vital capacity (FVC) is a reliable, valid, and responsive measure of clinical status in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 A comparison between total lung capacity and effective alveolar volume in patients with restrictive lung disease Source: Eur Respir J 2005; 26: Suppl. 49, 180s Year: 2005 Relationships between angiogenic activity of sera from interstitial lung disease (ILD) patients and lung function tests Source: Eur Respir J 2002; 20: Suppl. 38, 106s Year: 2002 Comparison of functional residual capacity (FRC) measured by plethysmography (FRCpleth) and multiple breath washout (FRCmbw) in schoolchildren with cystic fibrosis (CF). Source: International Congress 2018 – Respiratory physiology and measurements Year: 2018